Literature DB >> 10549250

Differential MUC 1 expression in normal and neoplastic human pancreatic tissue. An immunohistochemical study of 60 samples.

G M Monges1, M P Mathoulin-Portier, R B Acres, G F Houvenaeghel, M F Giovannini, J F Seitz, V J Bardou, M J Payan, D Olive.   

Abstract

Neoplastic transformation of epithelial cell sis commonly associated with altered synthesis of mucin glycoproteins. Few studies have been performed on the correlation between MUC 1 expression and pancreatic carcinoma using immunohistochemical methods. We compared the patterns of MUC 1 expression in normal pancreatic tissue, in pancreatic carcinoma, and in chronic pancreatitis. Immunohistochemical studies were performed using 3 monoclonal anti-MUC 1 antibodies (12C10, 1G5, and H23) on surgical specimens and on fine-needle aspiration biopsy specimens. In the neoplastic cells from adenocarcinomas, high levels of cytoplasmic MUC 1 expression were observed, with some membrane staining. No such cytoplasmic expression was observed in normal tissue, tissue from chronic pancreatitis, or benign neoplastic tissue. These data show conspicuous quantitative and qualitative differences between the patterns of MUC 1 expression observed in nonmalignant vs malignant pancreatic tissue and may be useful in the histologic diagnosis of adenocarcinoma in biopsy samples.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10549250     DOI: 10.1093/ajcp/112.5.635

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  8 in total

Review 1.  The molecular and cellular heterogeneity of pancreatic ductal adenocarcinoma.

Authors:  Nardin Samuel; Thomas J Hudson
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-12-20       Impact factor: 46.802

Review 2.  MUC1 and MUC2 in pancreatic neoplasia.

Authors:  E Levi; D S Klimstra; A Andea; O Basturk; N V Adsay
Journal:  J Clin Pathol       Date:  2004-05       Impact factor: 3.411

3.  A reappraisal of preoperative chemoradiation for localized pancreatic head ductal adenocarcinoma in a 5-year single-institution experience.

Authors:  V Moutardier; O Turrini; L Huiart; F Viret; M H Giovannini; V Magnin; B Lelong; E Bories; J Guiramand; A Sannini; M Giovannini; G Houvenaeghel; J L Blache; J C Moutardier; J R Delpero
Journal:  J Gastrointest Surg       Date:  2004 May-Jun       Impact factor: 3.452

Review 4.  Drug development in pancreatic cancer: finally, biology begets therapy.

Authors:  Steven J Cohen; Neal J Meropol
Journal:  Int J Gastrointest Cancer       Date:  2002

5.  Prognostic significance of membrane-associated mucins 1 and 4 in gastric adenocarcinoma.

Authors:  Ilseon Hwang; Yu Na Kang; Jin Young Kim; Young Rok DO; Hong Suk Song; Keon Uk Park
Journal:  Exp Ther Med       Date:  2012-06-01       Impact factor: 2.447

6.  Intercalated duct cell is starting point in development of pancreatic ductal carcinoma?

Authors:  Ryo Wada; Kaoru Ogawa; Toshikazu Yamaguchi; Takayuki Tanizaki; Michio Matsumoto
Journal:  J Carcinog       Date:  2005-07-14

Review 7.  The MUC gene family: their role in diagnosis and early detection of pancreatic cancer.

Authors:  Jörg Ringel; Matthias Löhr
Journal:  Mol Cancer       Date:  2003-01-07       Impact factor: 27.401

8.  MUC1-C nuclear localization drives invasiveness of renal cancer cells through a sheddase/gamma secretase dependent pathway.

Authors:  Audrey Bouillez; Viviane Gnemmi; Kelly Gaudelot; Brigitte Hémon; Bélinda Ringot; Nicolas Pottier; François Glowacki; Caroline Butruille; Christelle Cauffiez; Malika Hamdane; Nicolas Sergeant; Isabelle Van Seuningen; Xavier Leroy; Sébastien Aubert; Michaël Perrais
Journal:  Oncotarget       Date:  2014-02-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.